European Innovation Council

Sparrow Quantum A/S is a privately held company that develops and commercializes photonic quantum technology components based on research and patents developed in the Niels Bohr Institute Quantum Photonics Lab. The Niels Bohr Institute’s Quantum Photonics Lab, headed by professor Peter Lodahl, is part of the Danish Center for Quantum Innovation, Qubiz, funded by Innovation Fund Denmark –– a national large scale investment in quantum technologies.

STAC Technology is a research and development company based in Hellerup, Denmark, that specializes in sustainable thermal advanced cooling systems utilizing water as a refrigerant. Founded in 2016, the company focuses on transforming the district heating industry by enabling it to provide both heating and cooling services, thereby enhancing its business model. STAC's innovative water vapor-driven turbo compressor technology harnesses thermal energy from water to deliver on-site heating and cooling solutions that are zero-emission and highly efficient. By offering these sustainable solutions, STAC Technology helps clients minimize infrastructure costs, accelerate product development, mitigate project risks, and optimize supply chains while contributing to the fight against climate change.

Sparrow Quantum A/S is a privately held company that develops and commercializes photonic quantum technology components based on research and patents developed in the Niels Bohr Institute Quantum Photonics Lab. The Niels Bohr Institute’s Quantum Photonics Lab, headed by professor Peter Lodahl, is part of the Danish Center for Quantum Innovation, Qubiz, funded by Innovation Fund Denmark –– a national large scale investment in quantum technologies.

MedTrace Pharma A/S is a medical device company based in Kongens Lyngby, Denmark, with additional offices in Boston, Massachusetts, and Uppsala, Sweden. Founded in 2015, the company specializes in the development of innovative solutions for positron emission tomography (PET) imaging. Its flagship product, the MT-100, is an automated system designed for on-site production and infusion of the tracer 15O-water, which enhances the sensitivity of PET scans and improves patient throughput. MedTrace also offers aQuant, an analytical platform that interprets the PET scan results, enabling physicians to obtain accurate blood flow measurements in various clinical applications, including heart studies and tumor vascularization. The integration of these technologies aims to revolutionize PET diagnostic imaging by providing safer and more efficient tools for healthcare professionals.

NIL Technology ApS is a nanotechnology company based in Kongens Lyngby, Denmark, with a branch in Gothenburg, Sweden. Established in 2006, the company specializes in the optical design, prototyping, and mass production of optical components. NIL Technology offers nanostructured masters for various replication technologies, such as nanoimprint, UV-replication, hot embossing, roll printing, and injection molding. Its product range includes diffractive optical elements, microlens arrays, beam splitters, optical diffusers, and waveguides for augmented and mixed reality applications. The company's solutions cater to diverse sectors, including biotechnology, renewable energy, consumer product packaging, and advanced imaging technologies. By focusing on optical applications for sensors, 3D displays, and smartphones, NIL Technology aims to enable innovative optical solutions for a variety of high-tech industries.

Cellugy is a biotechnology startup focused on creating sustainable alternatives to single-use plastics through the production of 100% natural bio-cellulose. Utilizing a fermentation platform, the company harnesses renewable resources instead of fossil fuels to develop high-quality cellulose that competes effectively in terms of economics and environmental impact. Cellugy's innovative approach allows for the production of various grades and qualities of cellulose, making it applicable across multiple industries, including personal care, packaging, textiles, and food. By offering a more sustainable solution, Cellugy aims to significantly reduce the environmental footprint associated with traditional materials.

Electrochaea GmbH develops and commercializes a grid-scale power-to-gas energy storage technology. The company’s biocatalytic power-to-gas technology converts low-cost and stranded electricity into pipeline-grade renewable gas for direct injection into the existing natural gas grid, which is used for on-site power production, heating applications, or transmitted over long distances using existing pipelines. Its technology enables storing large amounts of renewable energy from wind and solar; and represents a solution for utility-scale energy storage, grid balancing, and carbon recycling. Electrochaea GmbH was founded in 2010 and is based in Planegg, Germany with additional operation facilities at Hvidovre, Denmark, and Sacramento, California.

FluoGuide A/S is a Copenhagen-based company that focuses on developing surgical solutions to enhance cancer treatment outcomes. Founded in 2018, the company is known for its product FG001, which utilizes a fluorophore that specifically binds to cancer cells expressing the urokinase receptor. By employing intelligent targeting techniques, FluoGuide aims to improve surgical precision, thereby reducing patient suffering and increasing the chances of successful treatment. Additionally, the company seeks to lower healthcare costs associated with cancer surgeries.

ATLANT 3D Nanosystems is a global pioneer combining unique advanced technologies to enable atomic layer 3D printing. The company was founded in 2018 by Dr. Maksym Plakhotnyuk, Ivan Kundrata, and Prof. Dr. Julien Bachmann with a vision of delivering the first-ever atomic layer 3D printing technology to reshape the future atom by atom. Our state-of-the-art atomic layer 3D printing technology is a true European creation, supported by three major European universities: Technical University of Denmark, Institute of Electrical Engineering Slovak Academy of Sciences, and Friedrich Alexander University Erlangen-Nuremberg.

MedTrace Pharma A/S is a medical device company based in Kongens Lyngby, Denmark, with additional offices in Boston, Massachusetts, and Uppsala, Sweden. Founded in 2015, the company specializes in the development of innovative solutions for positron emission tomography (PET) imaging. Its flagship product, the MT-100, is an automated system designed for on-site production and infusion of the tracer 15O-water, which enhances the sensitivity of PET scans and improves patient throughput. MedTrace also offers aQuant, an analytical platform that interprets the PET scan results, enabling physicians to obtain accurate blood flow measurements in various clinical applications, including heart studies and tumor vascularization. The integration of these technologies aims to revolutionize PET diagnostic imaging by providing safer and more efficient tools for healthcare professionals.

Klikkit is a welfare technology platform that focuses on home care, care homes, and hospitals. It specializes in telehealth platforms, health, healthcare, home care, care center, hospitals, digital innovation, digital solutions, technology trends, innovation, and health care management. Klikkit was founded in the year 2018.

Developer of a medical platform intended to deliver clinical decision support for remote care of heart patients with pacemakers. The company's platform leverages machine learning and ethnography to monitor cardiac devices remotely and uses advanced analytics to predict health conditions, enabling chronic patients with digital healthcare that monitors implanted cardiac devices.

Hafnium Labs supports chemicals, energy, and pharma companies by solving one of the biggest challenges in chemistry: Obtaining reliable physical properties fast. From drugs that save our lives, to crop and energy technologies that will save our tomorrow, advances in chemistry change the world. By supporting researchers and engineers working with chemistry we help create a brighter future. We have developed a breakthrough system for combining state-of-the-art predictive methods, such as quantum chemistry and AI, with experimental physical property data. By intelligently and transparently using all available information, we provide the most accurate physical property predictions and quantify the uncertainty, so you know how reliable each prediction is.​ Our Q-props™ tools support decision making from molecular discovery to process optimization. ​Check out our website and reach out to learn more about how to use Q-props™ in your company.